Free Trial

Teamwork Financial Advisors LLC Buys New Position in Astera Labs, Inc. $ALAB

Astera Labs logo with Computer and Technology background

Key Points

  • Teamwork Financial Advisors LLC acquired 2,495 shares of Astera Labs, Inc. for approximately $226,000 in the second quarter, indicating increasing interest in the semiconductor company.
  • Several hedge funds, including Vanguard Group and AllianceBernstein, have significantly increased their stakes in Astera Labs, with institutional investors now owning 60.47% of the stock.
  • Astera Labs reported a 149.5% year-over-year revenue increase, achieving $191.93 million with earnings per share of $0.44, surpassing analysts' expectations.
  • MarketBeat previews the top five stocks to own by October 1st.

Teamwork Financial Advisors LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 2,495 shares of the company's stock, valued at approximately $226,000.

A number of other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Astera Labs by 0.9% during the first quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock worth $554,780,000 after acquiring an additional 85,846 shares during the period. Alliancebernstein L.P. lifted its stake in Astera Labs by 114.2% during the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock valued at $501,289,000 after buying an additional 4,478,741 shares in the last quarter. Atreides Management LP boosted its holdings in shares of Astera Labs by 153.3% in the first quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock worth $277,601,000 after buying an additional 2,815,614 shares during the period. Fred Alger Management LLC boosted its holdings in shares of Astera Labs by 13.0% in the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after buying an additional 179,638 shares during the period. Finally, Altimeter Capital Management LP boosted its holdings in shares of Astera Labs by 68.0% in the first quarter. Altimeter Capital Management LP now owns 981,697 shares of the company's stock worth $58,578,000 after buying an additional 397,267 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. Needham & Company LLC raised their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Susquehanna lifted their price target on Astera Labs from $80.00 to $125.00 and gave the company a "neutral" rating in a report on Thursday, August 7th. Stifel Nicolaus set a $145.00 price target on Astera Labs and gave the company a "buy" rating in a research report on Monday, August 4th. Deutsche Bank Aktiengesellschaft raised their price objective on Astera Labs from $160.00 to $200.00 and gave the stock a "buy" rating in a research report on Tuesday, September 2nd. Finally, William Blair started coverage on Astera Labs in a report on Thursday, May 22nd. They issued an "outperform" rating on the stock. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $142.00.

View Our Latest Analysis on ALAB

Insider Buying and Selling

In other news, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the transaction, the director owned 385,863 shares of the company's stock, valued at $66,858,482.01. This trade represents a 32.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Jitendra Mohan sold 152,517 shares of the business's stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $170.33, for a total transaction of $25,978,220.61. Following the completion of the sale, the chief executive officer owned 450,001 shares of the company's stock, valued at $76,648,670.33. The trade was a 25.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 1,832,489 shares of company stock valued at $264,172,396 over the last 90 days. 12.50% of the stock is currently owned by insiders.

Astera Labs Stock Performance

Shares of NASDAQ ALAB traded up $1.79 during trading hours on Monday, hitting $231.29. The stock had a trading volume of 3,248,667 shares, compared to its average volume of 4,959,556. The company has a market capitalization of $38.44 billion, a P/E ratio of 413.02, a P/E/G ratio of 5.82 and a beta of 1.48. The firm's 50-day moving average price is $155.12 and its two-hundred day moving average price is $104.02. Astera Labs, Inc. has a 52 week low of $42.80 and a 52 week high of $237.82.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 EPS for the quarter, beating the consensus estimate of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The firm's quarterly revenue was up 149.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. As a group, analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Astera Labs Company Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

See Also

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.